Skip to main content

Table 7 Per protocol analysis of mean and median wound survival time (days)

From: A randomized controlled phase IIb wound healing trial of cutaneous leishmaniasis ulcers with 0.045% pharmaceutical chlorite (DAC N-055) with and without bipolar high frequency electro-cauterization versus intralesional antimony in Afghanistan

 

Per protocol (PP) evaluation

 

Group I

Group II

Group III

Overall

Mean (95% CI)

69 (49-89)

33 (29-37)

45 (34-56)

49 (41-57)

Median (95% CI)

63 (47-79)

32 (27-37)

35 (21-49)

37 (31-43)